ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,975Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 2888

$1.84M Total Retail Price of All Prescriptions

Rank: 38 out of 2888

607 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

27% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 28,592 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,256 1,153 1 2
DONEPEZIL HCL 1,020 997 2 26
FUROSEMIDE 1,007 927 3 6
NAMENDA 890 877 4 34
LEVOTHYROXINE SODIUM 859 813 5 1
HYDROCODONE-ACETAMINOPHEN 804 673 S3 6 4
WARFARIN SODIUM 752 698 7 22
LISINOPRIL 718 640 8 3
AMLODIPINE BESYLATE 703 622 9 5
POTASSIUM CHLORIDE 657 617 10 14
METOPROLOL TARTRATE 576 536 11 10
CARVEDILOL 520 486 12 21
OMEPRAZOLE 460 363 13 7
TRAZODONE HCL 450 394 14 43
GABAPENTIN 443 367 15 13
MIRTAZAPINE 433 420 16 54
SERTRALINE HCL 424 409 17 27
CITALOPRAM HBR 390 354 18 24
FAMOTIDINE 389 366 19 75
TRAMADOL HCL 386 351 20 16
ESCITALOPRAM OXALATE 371 336 21 62
RANITIDINE HCL 369 329 22 56
RAMIPRIL 361 314 23 73
QUETIAPINE FUMARATE 338 297 24 66
NOVOLOG FLEXPEN 324 267 25 171
ALENDRONATE SODIUM 303 241 26 23
LEVEMIR FLEXPEN 274 237 27 156
METFORMIN HCL 254 216 28 8
RISPERIDONE 250 215 29 72
DIOVAN 250 250 29 35
NOVOLIN R 250 236 29 109
CYMBALTA 248 182 32 44
TAMSULOSIN HCL 240 227 33 29
LEVETIRACETAM 225 162 34 103
LANTUS 221 200 35 45
CARBIDOPA-LEVODOPA 213 195 36 113
FLUTICASONE PROPIONATE 203 180 37 32
HYDROCHLOROTHIAZIDE 198 185 38 15
LYRICA 195 150 39 69
DIVALPROEX SODIUM 195 171 39 100
DIGOXIN 194 193 41 55
METOPROLOL SUCCINATE 193 190 42 11
ATORVASTATIN CALCIUM 186 160 43 9
IPRATROPIUM-ALBUTEROL 182 172 44 150
HYDRALAZINE HCL 177 140 45 59
CLOPIDOGREL 172 155 46 30
KLOR-CON M10 168 168 47 118
CLONIDINE HCL 168 161 47 39
ALBUTEROL SULFATE 163 155 49 134
NOVOFINE AUTOCOVER 162 144 10 50 410
LATANOPROST 151 140 51 197
PLAVIX 150 134 52 40
ZOLPIDEM TARTRATE 145 93 53 17
KLOR-CON M20 145 129 53 90
NOVOLIN 70-30 141 127 55 144
AMOX TR-POTASSIUM CLAVULANATE 139 128 56 112
GLIPIZIDE 136 122 57 50
OLANZAPINE 133 120 58 137
PROMETHAZINE HCL 132 113 R 59 96
NYSTATIN 132 120 59 178
PHENYTOIN SODIUM EXTENDED 132 106 59 128
SEROQUEL 130 123 62 143
TRAVATAN Z 128 126 63 239
AMIODARONE HCL 122 110 64 167
BACLOFEN 122 65 64 121
PRAVASTATIN SODIUM 117 112 66 12
NOVOLOG MIX 70-30 FLEXPEN 117 110 66 226
PANTOPRAZOLE SODIUM 116 106 68 33
EXELON 115 115 69 106
MELOXICAM 115 101 69 31
MEGESTROL ACETATE 112 110 R 71 140
ISOSORBIDE MONONITRATE ER 111 94 72 51
ATENOLOL 108 108 73 25
LEXAPRO 106 95 74 198
NIFEDIPINE ER 104 104 75 76
FLUOXETINE HCL 103 102 76 83
TRICOR 100 67 77 91
OXYBUTYNIN CHLORIDE ER 99 97 78 132
CIPROFLOXACIN HCL 99 89 78 47
MEGACE ES 96 89 R 80 310
NEXIUM 95 86 81 19
LACTULOSE 91 67 82 111
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 82 83 88
ABILIFY 89 64 84 172
PREDNISONE 87 71 85 42
DOXYCYCLINE HYCLATE 87 75 85 123
ALLOPURINOL 87 86 85 37
ADVAIR DISKUS 87 86 85 60
SPIRIVA 84 67 89 79
BUSPIRONE HCL 83 80 90 148
POLYETHYLENE GLYCOL 3350 83 79 90 93
SINGULAIR 81 72 92 85
IPRATROPIUM BROMIDE 81 78 92 188
FINASTERIDE 81 81 92 102
CRESTOR 80 75 95 20
DIVALPROEX SODIUM ER 80 61 95 185
BYSTOLIC 78 68 97 99
LEVOFLOXACIN 78 74 97 57
VENLAFAXINE HCL ER 77 62 99 120
DETROL LA 75 62 100 192
HYDROXYZINE HCL 71 63 R 101 174
SPIRONOLACTONE 70 56 102 70
OXYBUTYNIN CHLORIDE 68 60 103 124
DOXAZOSIN MESYLATE 66 66 104 94
LOSARTAN POTASSIUM 64 58 105 18
GLYBURIDE 64 57 R 105 58
GLUCAGEN 63 58 107 288
NITROFURANTOIN MONO-MACRO 63 51 107 162
HUMULIN R 62 56 109 233
TORSEMIDE 62 62 109 158
BENAZEPRIL HCL 62 62 109 77
METOCLOPRAMIDE HCL 61 56 112 116
AGGRENOX 61 47 112 223
INSULIN SYRINGE 61 59 112 86
MUPIROCIN 59 54 115 184
PEN NEEDLE 59 49 115 110
PHENYTOIN 57 56 117 302
TRIAMCINOLONE ACETONIDE 55 48 118 145
BRIMONIDINE TARTRATE 53 53 119 338
LOVAZA 52 34 120 97
NITROFURANTOIN 51 42 121 241
DILTIAZEM ER 51 51 121 182
FELODIPINE ER 50 50 123 175
ZETIA 50 25 123 81
MONTELUKAST SODIUM 50 48 123 153
NOVOLOG 50 49 123 114
TIMOLOL MALEATE 50 50 123 348
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.